I-Mab Biopharma
IMAB
$1.81
Share price
0.56%
Change (1 day)
-43.08%
Change (1 year)
Categories
Market capitalization of I-Mab Biopharma (IMAB)
Market cap: $0.14 Billion
As of April 2024 I-Mab Biopharma has a market cap of $0.14 Billion. This makes I-Mab Biopharma the world's 7162th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of I-Mab Biopharma from 2020 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.14 B | -6.95% |
| 2023 | $0.15 B | -54.81% |
| 2022 | $0.34 B | -90.83% |
| 2021 | $3.78 B | 12.05% |
| 2020 | $3.38 B |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of I-Mab Biopharma was reported to be:
$0.14 Billion
$0.14 Billion
$0.15 Billion
$0.14 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.85 B | 486.91% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.9 M | -85.69% | 🇺🇸 USA |